Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association
Article Information
vol. 37 no. 7 2034-2054
PubMed
Published By
Print ISSN
Online ISSN
History
- Published in print June 24, 2014.
- Published online ahead of print June 16, 2014.
Article Versions
- Previous version (June 16, 2014 - 12:54).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2014 by the American Diabetes Association. Readers may use the content as long as the work is properly cited and linked to the original source, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
Author Information
- Jane L. Chiang1⇑,
- M. Sue Kirkman2,
- Lori M.B. Laffel3 and
- Anne L. Peters4
- on behalf of the Type 1 Diabetes Sourcebook Authors*
- 1American Diabetes Association, Alexandria, VA
- 2Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
- 3Pediatric, Adolescent and Young Adult Section, Joslin Diabetes Center; Department of Pediatrics, Harvard Medical School, Boston, MA
- 4Division of Endocrinology, Keck School of Medicine of the University of Southern California, Los Angeles, CA
- Corresponding author: Jane L. Chiang, jchiang{at}diabetes.org.
Statistics from Altmetric.com
Article usage
In this Issue
July 2014, 37(7)
Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association
Jump to section
- Article
- Incidence and Prevalence of Type 1 Diabetes
- Classification and Diagnosis
- Initial Evaluation and Follow-up
- DSME and DSMS
- Psychosocial: Assessment and Treatment of Psychosocial Issues
- Nutrition Therapy
- Physical Activity and Exercise
- Treatment Targets
- Monitoring
- A1C Testing
- Insulin Therapy
- Interdiction
- β-Cell Replacement Therapy
- Adjunctive Therapies
- Hypoglycemia
- DKA
- CVD Screening and Treatment
- Specific Settings and Populations
- Article Information
- Footnotes
- References
- Figures & Tables
- Info & Metrics